DLBCL
2 stories
-
healthLymphocyte Growth Rate Key Predictor for CAR-T Therapy Success in Lymphoma
New research reveals lymphocyte expansion speed post-CAR-T therapy is a critical biomarker for predicting survival and toxicity in lymphoma patients.
-
healthR-CHOP Retreatment Shows Promise for Late Relapse Lymphoma
New research indicates that re-treating diffuse large B-cell lymphoma patients with R-CHOP can lead to durable responses and improved outcomes, particularly for those with late relapses.